GANX
Price
$2.85
Change
-$0.14 (-4.68%)
Updated
Nov 14, 11:13 AM (EDT)
Capitalization
107.31M
125 days until earnings call
Intraday BUY SELL Signals
GDTC
Price
$1.92
Change
-$0.00 (-0.00%)
Updated
Nov 14, 11:09 AM (EDT)
Capitalization
22.76M
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GANX vs GDTC

Header iconGANX vs GDTC Comparison
Open Charts GANX vs GDTCBanner chart's image
Gain Therapeutics
Price$2.85
Change-$0.14 (-4.68%)
Volume$200
Capitalization107.31M
CytoMed Therapeutics
Price$1.92
Change-$0.00 (-0.00%)
Volume$1K
Capitalization22.76M
GANX vs GDTC Comparison Chart in %
GANX
Daily Signal:
Gain/Loss:
GDTC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GANX vs. GDTC commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Hold and GDTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (GANX: $2.99 vs. GDTC: $1.92)
Brand notoriety: GANX and GDTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 216% vs. GDTC: 22%
Market capitalization -- GANX: $107.31M vs. GDTC: $22.76M
GANX [@Biotechnology] is valued at $107.31M. GDTC’s [@Biotechnology] market capitalization is $22.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileGDTC’s FA Score has 0 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • GDTC’s FA Score: 0 green, 5 red.
According to our system of comparison, GDTC is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 5 TA indicator(s) are bullish while GDTC’s TA Score has 3 bullish TA indicator(s).

  • GANX’s TA Score: 5 bullish, 5 bearish.
  • GDTC’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GANX is a better buy in the short-term than GDTC.

Price Growth

GANX (@Biotechnology) experienced а +57.37% price change this week, while GDTC (@Biotechnology) price change was -5.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Reported Earning Dates

GANX is expected to report earnings on Mar 19, 2026.

GDTC is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GANX($107M) has a higher market cap than GDTC($22.8M). GANX YTD gains are higher at: 38.426 vs. GDTC (-43.529).
GANXGDTCGANX / GDTC
Capitalization107M22.8M469%
EBITDA-17.16MN/A-
Gain YTD38.426-43.529-88%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash6.69MN/A-
Total Debt681KN/A-
TECHNICAL ANALYSIS
Technical Analysis
GANXGDTC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 26 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signal:
Gain/Loss:
GDTC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COSM0.73N/A
-0.48%
Cosmos Health
SLS1.46-0.03
-2.01%
SELLAS Life Sciences Group
WDC157.16-8.95
-5.39%
Western Digital Corp
NAK1.73-0.10
-5.46%
Northern Dynasty Minerals Ltd
ZETA18.51-1.96
-9.57%
Zeta Global Holdings Corp

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+1.36%
COYA - GANX
42%
Loosely correlated
-2.13%
COGT - GANX
38%
Loosely correlated
-4.06%
TRDA - GANX
38%
Loosely correlated
+9.61%
ELVN - GANX
37%
Loosely correlated
-0.15%
MGTX - GANX
37%
Loosely correlated
-4.62%
More

GDTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GDTC has been loosely correlated with CYCN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GDTC jumps, then CYCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-0.52%
CYCN - GDTC
35%
Loosely correlated
+1.41%
CVKD - GDTC
29%
Poorly correlated
-4.82%
QSI - GDTC
28%
Poorly correlated
-8.55%
ADIL - GDTC
27%
Poorly correlated
-3.01%
GANX - GDTC
25%
Poorly correlated
+1.36%
More